HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

POEMS syndrome: definitions and long-term outcome.

Abstract
The POEMS syndrome (coined to refer to polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes) remains poorly understood. Ambiguity exists over the features necessary to establish the diagnosis, treatment efficacy, and prognosis. We identified 99 patients with POEMS syndrome. Minimal criteria were a sensorimotor peripheral neuropathy and evidence of a monoclonal plasmaproliferative disorder. To distinguish POEMS from neuropathy associated with monoclonal gammopathy of undetermined significance, additional criteria were included: a bone lesion, Castleman disease, organomegaly (or lymphadenopathy), endocrinopathy, edema (peripheral edema, ascites, or effusions), and skin changes. The median age at presentation was 51 years; 63% were men. Median survival was 165 months. With the exception of fingernail clubbing (P =.03) and extravascular volume overload (P =.04), no presenting feature, including the number of presenting features, was predictive of survival. Response to therapy (P <.001) was predictive of survival. Pulmonary hypertension, renal failure, thrombotic events, and congestive heart failure were observed and appear to be part of the syndrome. In 18 patients (18%), new disease manifestations developed over time. More than 50% of patients had a response to radiation, and 22% to 50% had responses to prednisone and a combination of melphalan and prednisone, respectively. We conclude that the median survival of patients with POEMS syndrome is 165 months, independent of the number of syndrome features, bone lesions, or plasma cells at diagnosis. Additional features of the syndrome often develop, but the complications of classic multiple myeloma rarely develop.
AuthorsAngela Dispenzieri, Robert A Kyle, Martha Q Lacy, S Vincent Rajkumar, Terry M Therneau, Dirk R Larson, Philip R Greipp, Thomas E Witzig, Rita Basu, Guillermo A Suarez, Rafael Fonseca, John A Lust, Morie A Gertz
JournalBlood (Blood) Vol. 101 Issue 7 Pg. 2496-506 (Apr 01 2003) ISSN: 0006-4971 [Print] United States
PMID12456500 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Cardiomyopathies (etiology)
  • Diagnosis, Differential
  • Glomerulonephritis (etiology)
  • Humans
  • Hypertension, Pulmonary (etiology)
  • Lung Diseases (etiology)
  • Male
  • Middle Aged
  • POEMS Syndrome (complications, diagnosis, mortality, therapy)
  • Prognosis
  • Retrospective Studies
  • Thrombosis (etiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: